Work

Real-world data comparing FOLFIRINOX versus gemcitabine nab-paclitaxel as first-line treatment of metastatic pancreatic ductal adenocarcinoma patients in the United States.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.e16271

Authors: Avital Klein-Brill, Shlomit Amar-Farkash, Gabriella Lawrence, Eric Andrew Collisson, Michael Jordan Fisch, Dvir Aran

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Technion – Israel Institute of Technology

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281779225

Cites:

Cited by: 1

Related to: 10